This is a preprint.
High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi
- PMID: 32766597
- PMCID: PMC7402052
- DOI: 10.1101/2020.07.30.20164970
High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi
Update in
- This article has been published with doi: 10.12688/wellcomeopenres.16188.1
Abstract
Background: In low-income countries, like Malawi, important public health measures including social distancing or a lockdown have been challenging to implement owing to socioeconomic constraints, leading to predictions that the COVID-19 pandemic would progress rapidly. However, due to limited capacity to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, there are no reliable estimates of the true burden of infection and death. We, therefore, conducted a SARS-CoV-2 serosurvey amongst health care workers (HCWs) in Blantyre city to estimate the cumulative incidence of SARS-CoV-2 infection in urban Malawi.
Methods: We recruited 500 otherwise asymptomatic HCWs from Blantyre City (Malawi) from 22nd May 2020 to 19th June 2020 and serum samples were collected from all participants. A commercial ELISA was used to measure SARS-CoV-2 IgG antibodies in serum.
Results: A total of 84 participants tested positive for SARS-CoV-2 antibodies. The HCWs with positive SARS-CoV-2 antibody results came from different parts of the city. The adjusted seroprevalence of SARS-CoV-2 antibodies was 12.3% [CI 8.2 - 16.5]. Using age-stratified infection fatality estimates reported from elsewhere, we found that at the observed adjusted seroprevalence, the number of predicted deaths was eight times the number of reported deaths.
Conclusions: The high seroprevalence of SARS-CoV-2 antibodies among HCWs and the discrepancy in the predicted versus reported deaths suggests that there was early exposure but slow progression of COVID-19 epidemic in urban Malawi. This highlights the urgent need for development of locally parameterised mathematical models to more accurately predict the trajectory of the epidemic in sub-Saharan Africa for better evidence-based policy decisions and public health response planning.
Keywords: COVID-19; IgG; Malawi; SARS-CoV-2; Seroprevalence.
Conflict of interest statement
Competing interests E.R.A. and R.L.B. worked with Mologic (UK) to independently validate the SARS-CoV-2 ELISA at the Liverpool School of Tropical Medicine (LSTM). All other authors report no potential conflicts.
Figures


References
-
- JHU. COVID-19 Case Tracker 2020. [cited; Available from: https://coronavirus.ihu.edu/map.html.
-
- CDC A. Latest updates on the COVID-19 crisis from Africa CDC. 2020. [cited 2020 15.07.2020]; Available from:
-
- PHIM. Daily COVID--19 Situation Report. Lilongwe: Public Health Institute of Malawi, Ministry of Health; 2020. 1st July 2020.
Publication types
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous